Medicis to buy back remaining 1.5% convertibles

By Devika Patel

Knoxville, Tenn., Aug. 11 - Medicis Pharmaceutical Corp. announced in a 10-Q filed Monday with the Securities and Exchange Commission that it plans to redeem all $181,000 of its remaining 1.5% contingent convertible senior notes due 2033 during the second half of 2008.

The company was forced to repurchase the $283.7 million of its $283.9 million of outstanding convertibles on June 4 when the investors exercised their put option.

Deutsche Bank Trust Co. Americas is the trustee and paying agent.

Medicis is a pharmaceutical company based in Scottsdale, Ariz.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.